sanofi (SAN:EN Paris)
Chief Strategy Officer and Executive Vice President, Sanofi
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Dr. David-Alexandre Gros has been the Chief Strategy Officer at Sanofi since September 1, 2011 and serves as its Executive Vice President. Dr. Gros covers all Group business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management. Dr. Gros was an advisor to pharmaceutical, biotechnology and diagnostic companies as a Principal and founding member of the Healthcare Investment ...
54, Rue La BoétiePhone: 33 1 53 77 40 00
Paris, Ile-de-France 75008
Board Members Memberships*There is no Board Members Memberships data available.
Harvard Business School
Johns Hopkins School of Medicine
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Marijn E. Dekkers Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Andrew Philip Witty||Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee|
|Kenneth C. Frazier||Chairman and Chief Executive Officer|
Merck & Co. Inc.
|$1.5M||Compensation as of Fiscal Year 2013.|